Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 103 Lymphoma 67 Lymphoma, Large B-Cell, Diffuse 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Sarcoma 33 Lymphoma, Non-Hodgkin 29 Hodgkin Disease 27 Leukemia 23 Burkitt Lymphoma 22 Neoplasms 19 Lymphoma, Mantle-Cell 18 Triple Negative Breast Neoplasms 15 Multiple Myeloma 15 Lymphoma, Follicular 15 Lymphoma, B-Cell 14 Lymphoma, Large-Cell, Anaplastic 12 Carcinoma, Hepatocellular 12 Breast Neoplasms, Male 11 Neuroblastoma 10 Recurrence 9 Ovarian Neoplasms 9 Neoplasm Metastasis 9 Inflammatory Breast Neoplasms 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, T-Cell, Peripheral 8 Lymphoma, T-Cell 8 Osteosarcoma 7 Fallopian Tube Neoplasms 7 Urinary Bladder Neoplasms 6 Liposarcoma 6

Interventions

Nivolumab 11 Ipilimumab 6 linrodostat 4 relatlimab 3 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 mirdametinib 1 gedatolisib 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tetanus Toxoid 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Irinotecan 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Cyclophosphamide 1 Crizotinib 1 Cetuximab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡